OMEICOS

Description: OMEICOS develops first-in-class small molecule therapies for cardiovascular diseases like atrial fibrillation.

Country: Germany

Based in: Berlin

Founded: 2013

Funding Stage: Series A/B

Tags: ['BioTech', 'Pharmaceutical', 'Cardiovascular Research', 'Healthcare']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.